Skip to main content

MetLife income statement

  • MET · NYSE
  • Insurance
  • Life & Health Insurance
  • S&P 500
$102.65+0.77%Close 13 Nov 2026 · Market value $63.88B

MetLife reported revenue of $77.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 8.6% from fiscal 2024. Net income was $3.38 billion and diluted earnings per share $4.71.

From MetLife's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

MetLife income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$47.15B$50.98B$40.66B$52.25B$70.24B$68.15B$68.20B$73.32B$61.34B$60.79B$62.31B$67.94B$69.62B$67.84B$68.70B$68.77B$66.91B$70.99B$77.08B$82.56B
Revenue growth—+8.1%−20.3%+28.5%+34.4%−3.0%+0.1%+7.5%−16.3%−0.9%+2.5%+9.0%+2.5%−2.6%+1.3%+0.1%−2.7%+6.1%+8.6%—
Selling, general and administrative————————$7.53B$6.75B$6.52B$6.62B$6.90B$6.36B$6.13B$5.93B$6.65B$6.50B$7.35B$8.61B
Operating expenses$10.40B$11.95B$10.52B$12.93B$18.54B$17.75B$16.60B$17.09B$14.78B$13.75B$13.62B$13.71B$13.69B$13.15B$12.02B$11.86B$12.71B$13.02B$13.86B$15.22B
Operating income———————————————$5.98B$5.72B$6.00B$6.14B$6.74B
Operating margin———————————————8.7%8.6%8.4%8.0%8.2%
Interest expense—$1.05B$1.04B$1.55B$1.63B$1.36B$1.28B$1.22B$1.17B$1.16B$1.13B$1.12B$955.0M$913.0M$920.0M$938.0M$1.04B$1.04B$1.06B$1.11B
Income before tax——−$4.36B$3.73B$9.18B$1.44B$4.05B$8.80B$5.65B$4.28B$3.54B$6.31B$6.79B$6.93B$8.52B$6.36B$2.16B$5.62B$4.66B$6.66B
Income tax expense$1.68B$1.58B−$2.02B$1.11B$2.79B$128.0M$661.0M$2.46B$1.59B$693.0M−$1.47B$1.18B$886.0M$1.51B$1.64B$1.06B$560.0M$1.18B$1.26B$1.49B
Effective tax rate——46.4%29.8%30.4%8.9%16.3%28.0%28.1%16.2%−41.6%18.7%13.0%21.8%19.3%16.7%25.9%21.0%27.0%22.4%
Net income$4.32B$3.21B−$2.25B$2.67B$6.42B$1.32B$3.37B$6.31B$5.37B$850.0M$4.01B$5.12B$5.90B$5.41B$6.86B$5.28B$1.58B$4.43B$3.38B$5.13B
Net margin9.2%6.3%−5.5%5.1%9.1%1.9%4.9%8.6%8.8%1.4%6.4%7.5%8.5%8.0%10.0%7.7%2.4%6.2%4.4%6.2%
Net income to common shareholders—$3.08B−$2.37B$2.54B$6.16B$1.20B$3.25B$6.19B$5.21B$747.0M$3.91B$4.98B$5.72B$5.19B$6.65B$5.10B$1.38B$4.23B$3.17B$4.97B
EPS · diluted$5.48$4.14−$2.89$2.86$5.76$1.12$2.91$5.42$4.62$0.67$3.62$4.91$6.06$5.68$7.65$6.30$1.81$5.94$4.71$7.64
Diluted weighted average shares788M745M818M890M1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.0B944M913M869M809M762M711M673M651M
Basic weighted average shares—735M818M882M1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.0B938M908M863M803M758M706M669M647M
EBITDA———————————————$6.65B$6.44B$6.71B$6.89B—
EBITDA margin———————————————9.7%9.6%9.5%8.9%—
Depreciation & amortization$457.0M$150.0M$151.0M$193.0M$259.0M$358.0M$267.0M$264.0M$693.0M$652.0M$795.0M$628.0M$630.0M$619.0M$694.0M$673.0M$718.0M$714.0M$753.0M—
Stock-based compensation—$123.0M$69.00M$84.00M$144.0M$168.0M$175.0M$192.0M$137.0M$147.0M$128.0M$86.00M$150.0M$127.0M$173.0M$184.0M$171.0M$168.0M$131.0M—
Dividends per share$0.74$0.74$0.74$0.74$0.74$0.74$1.01$1.32$1.48$1.57$1.60$1.66$1.74$1.82$1.90$1.98$2.06$2.15$2.25$2.32

Quarterly

MetLife income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$19.03B$16.06B$17.82B$18.44B$18.67B$18.57B$17.34B$17.36B$23.81B$19.07B$19.15B$20.52B
Selling, general and administrative$1.76B$1.65B$1.61B$1.68B$1.56B$1.67B$1.74B$1.88B$2.06B$2.16B$2.19B$2.20B
Operating expenses$3.32B$3.22B$3.18B$3.26B$3.36B$3.35B$3.32B$3.51B$3.68B$3.80B$3.84B$3.89B
Operating income—$1.40B$1.66B$1.44B$1.49B$1.42B$1.39B$1.65B$1.68B$1.63B$1.60B$1.83B
Operating margin—8.7%9.3%7.8%8.0%7.6%8.0%9.5%7.1%8.6%8.4%8.9%
Interest expense$269.0M$264.0M$257.0M$257.0M$259.0M$258.0M$269.0M$271.0M$263.0M$265.0M$292.0M$291.0M
Income before tax$941.0M$1.04B$1.20B$1.99B$1.38B$1.35B$980.0M$1.21B$1.12B$1.51B$1.03B$3.00B
Income tax expense$327.0M$170.0M$249.0M$653.0M$106.0M$404.0M$245.0M$308.0M$301.0M$345.0M$256.0M$588.0M
Effective tax rate34.8%16.3%20.7%32.7%7.7%29.8%25.0%25.5%26.9%22.9%24.7%19.6%
Net income$607.0M$867.0M$946.0M$1.34B$1.27B$945.0M$729.0M$896.0M$809.0M$1.19B$736.0M$2.40B
Net margin3.2%5.4%5.3%7.3%6.8%5.1%4.2%5.2%3.4%6.2%3.8%11.7%
Net income to common shareholders$574.0M$800.0M$912.0M$1.27B$1.24B$879.0M$698.0M$818.0M$778.0M$1.14B$705.0M$2.35B
EPS · diluted$0.77$1.10$1.28$1.81$1.78$1.28$1.03$1.22$1.17$1.74$1.09$3.67
Diluted weighted average shares743M728M715M704M698M687M675M669M662M656M647M640M
Basic weighted average shares739M723M711M699M693M682M671M665M658M652M643M635M
EBITDA—————————$1.66B$1.64B$1.86B
EBITDA margin—————————8.7%8.6%9.0%
Depreciation & amortization—————————$29.00M$40.00M$31.00M
Dividends per share$0.52$0.52$0.55$0.55$0.54$0.55$0.57$0.57$0.57$0.57$0.59$0.59

The main figures as JSON and plain text. See data and methodology.

MET in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.